GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Bausch Health Companies
Bausch Health is a diversified pharmaceutical company. Its stock price reflects a long history of struggling with massive debt, legal challenges, and restructuring attempts through spinoffs of subsidiaries (Bausch + Lomb) to unlock value.
Share prices of companies in the market segment - Pharma holding
Bausch Health is a diversified pharmaceutical company with assets in gastroenterology and dermatology. We classify it as a pharmaceutical holding company, and the chart below shows the overall performance of this sector, although Bausch has its own history of restructuring.
Broad Market Index - GURU.Markets
Bausch Health is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology. Its scale makes it a significant component of the GURU.Markets index. The chart below represents the entire market. Find out how Bausch Health compares to the overall market dynamics.
Change in the price of a company, segment, and market as a whole per day
BHC - Daily change in the company's share price Bausch Health Companies
The daily price change of Bausch Health, a diversified pharmaceutical company, reflects the complexity of its business and high debt. Change_co measures volatility associated with the sale of key drugs and restructuring. This metric is important for building complex analytical models for valuing companies undergoing transformation on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Pharma holding
Bausch Health Companies Inc. is a diversified pharmaceutical company. This chart shows the average daily volatility of the sector. Comparing it to BHC's performance during a complex restructuring helps assess its unique risk profile compared to more stable players.
Daily change in the price of a broad market stock, index - GURU.Markets
Bausch Health is a diversified pharmaceutical company that has gone through a challenging period of restructuring and divestiture. Its history exemplifies how corporate events impact stocks. The chart below shows overall market volatility, providing context for Bausch Health's valuation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Bausch Health Companies
Bausch Health, a pharmaceutical company, has undergone a complex restructuring over the past year, spinning off its ophthalmology business, Bausch + Lomb. Its year-over-year share price performance, shown in the chart, reflects the market's assessment of this strategy and its massive debt.
Annual dynamics of market capitalization of the market segment - Pharma holding
Bausch Health Companies Inc. is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology. The company is undergoing a complex restructuring to reduce its massive debt. The chart will show how successful its efforts to stabilize the business are.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bausch Health is a complex story of transformation in the pharmaceutical sector. Its stock price reflects not so much economic cycles as the company's efforts to reduce its massive debt and grow its key brands. The chart isn't about the market, but about survival and the company's attempt to regain investor confidence after a series of scandals.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Bausch Health Companies
The performance of Bausch Health, a diversified pharmaceutical company, reflects its complex transformation. Monthly fluctuations on the chart depend on sales of its key brands, such as Xifaxan, and the company's progress in reducing its massive debt and resolving legal issues.
Monthly dynamics of market capitalization of the market segment - Pharma holding
Bausch Health is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. Its strategy is focused on debt repayment and the development of key brands. The pharmaceutical sector performance chart allows us to assess how the market perceives such holding companies compared to more innovative biotech companies.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Bausch Health is a diversified pharmaceutical company with a product portfolio across multiple sectors. Its history is burdened by significant debt, making its shares highly volatile. Amid market fluctuations, as shown in the chart, BHC's performance is often driven by news of debt restructurings and asset sales, rather than solely by operating performance.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Bausch Health Companies
Bausch Health, a diversified pharmaceutical company, shares reflect news across its entire product range. Weekly price movements are driven by sales of vision, gastrointestinal, and dermatology products, as well as news related to the company's large debt load. The chart below shows how short-term events and financial risks impact the holding's valuation.
Weekly dynamics of market capitalization of the market segment - Pharma holding
Is Bausch Health keeping pace with the pharmaceutical sector? The chart below compares the weekly performance of this diversified holding company's shares with the industry average. This allows us to assess whether its high debt and restructuring are having a greater impact than the overall pharmaceutical industry-wide drug news.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Bausch Health is a diversified pharmaceutical company with a large product portfolio. It also has a high debt load. This chart compares its weekly performance with the market to assess what influences its volatility more: the stability of its pharmaceutical business or the risks associated with its debt.
Market capitalization of the company, segment and market as a whole
BHC - Market capitalization of the company Bausch Health Companies
Bausch Health Companies' valuation is a complex story of transformation and struggle with massive debt. The valuation of a company with a diversified portfolio of pharmaceutical brands (including Bausch + Lomb) depends on its ability to generate cash flow to pay off its liabilities. The chart illustrates this challenging journey.
BHC - Share of the company's market capitalization Bausch Health Companies within the market segment - Pharma holding
Bausch Health Companies is a diversified pharmaceutical company with products in ophthalmology, gastroenterology, and dermatology. Its sector market capitalization reflects the combined value of its various business segments. The chart shows how investors view its debt reduction efforts and business spinoff strategy.
Market capitalization of the market segment - Pharma holding
This chart is a barometer of diversified pharmaceutical holdings. Bausch Health, with its portfolio ranging from ophthalmology to gastroenterology, is a major player. The dynamics on the chart reflect the company's complex history and its efforts to restructure and reduce its debt burden.
Market capitalization of all companies included in a broad market index - GURU.Markets
This chart depicts the market valuation of a diversified pharmaceutical giant. Bausch Health's market capitalization reflects the value of its businesses in eye care, gastroenterology, and dermatology. The dynamics show how the company, following its restructuring, is attempting to maintain its share of the global healthcare industry.
Book value capitalization of the company, segment and market as a whole
BHC - Book value capitalization of the company Bausch Health Companies
Here's a valuation of Bausch Health Companies' diversified assets. The chart reflects the combined value of its drug manufacturing plants, patents for ophthalmology drugs, gastroenterology products, and dermatology products. The dynamics show how the holding manages its broad healthcare portfolio.
BHC - Share of the company's book capitalization Bausch Health Companies within the market segment - Pharma holding
Bausch Health is a diversified pharmaceutical company whose tangible assets include manufacturing plants for medications, contact lenses, and ophthalmic equipment. The chart shows the company's share of this diverse manufacturing infrastructure, reflecting its broad reach into the healthcare sector.
Market segment balance sheet capitalization - Pharma holding
Bausch Health is a diversified pharmaceutical company. It owns a vast network of manufacturing facilities worldwide, making it highly capital-intensive compared to pure R&D companies. The chart below shows the total material weight of the entire sector, allowing one to assess this manufacturing power.
Book value of all companies included in the broad market index - GURU.Markets
Bausch Health's balance sheet consists of a diversified portfolio of dozens of pharmaceutical brands in gastroenterology and ophthalmology, as well as manufacturing plants. The company's assets are the combined value of its product line and manufacturing facilities, scattered around the world.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Bausch Health Companies
Bausch Health is a diversified pharmaceutical company with massive debt. Its balance sheet reflects the value of its brands and manufacturing facilities. Its market valuation trades at a significant discount to its asset value due to its debt load. The chart illustrates how investor concerns about debt can eat into the value of its very real assets.
Market to book capitalization ratio in a market segment - Pharma holding
Bausch Health is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology. The chart shows how the market values this complex asset portfolio, burdened with significant debt, reflecting investors' confidence in the company's ability to manage its debt.
Market to book capitalization ratio for the market as a whole
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology. The chart shows how the market values the company, which is heavily indebted. Its market capitalization often trades at a significant discount to the value of its brands and assets due to its debt load, which eats up a large portion of its profits.
Debts of the company, segment and market as a whole
BHC - Company debts Bausch Health Companies
Bausch Health is a diversified pharmaceutical company with a product portfolio across multiple areas. The company has a complex history, including a high debt load following a series of acquisitions. This chart shows the company's efforts to manage its debt, divest non-core assets, and focus on key growth areas.
Market segment debts - Pharma holding
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products across various therapeutic areas. The company has undergone a challenging debt restructuring. This chart, showing general standards for the pharmaceutical sector, provides important context for assessing how Bausch Health is managing its significant debt burden and pursuing growth.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Bausch Health Companies
Bausch Health is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. The company has historically had a very high debt load. This chart shows its current financial position and progress in debt reduction, a key objective for its management.
Market segment debt to market segment book capitalization - Pharma holding
Bausch Health is a diversified pharmaceutical company with a portfolio in ophthalmology, gastroenterology, and dermatology. This chart compares its significant debt, accumulated through past acquisitions, to the total market capitalization of its entire pharmaceutical sector. It highlights the company's efforts to restructure and reduce its debt burden.
Debt to book value of all companies in the market
Bausch Health has a complex history with a high debt load. This chart compares its massive debt to the overall market capitalization. It clearly illustrates the scale of the company's financial problems and its restructuring efforts in the context of the broader economy.
P/E of the company, segment and market as a whole
P/E - Bausch Health Companies
This chart for Bausch Health Companies, a diversified pharmaceutical company, shows its market valuation. For a holding company with a large product portfolio and significant debt load, this metric reflects how investors assess its ability to generate cash flow to service debt and grow its business.
P/E of the market segment - Pharma holding
This chart shows the average valuation for the pharmaceutical sector, particularly for diversified companies like Bausch Health. It reflects how investors generally value companies with a broad product portfolio and often high debt loads. It provides a benchmark for understanding how the market views Bausch Health's strategy.
P/E of the market as a whole
Bausch Health is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology. The company has undergone a complex transformation, focusing on its core brands. This chart helps understand how the market values companies undergoing restructuring and debt repayment.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Bausch Health Companies
Bausch Health Companies is a diversified pharmaceutical company with products in ophthalmology, gastroenterology, and dermatology. This chart shows how the market views its future profitability, weighing the growth of its key brands against the risks associated with its large debt burden and patent disputes.
%20P%2FE%20Bausch%20Health%20Companies&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Bausch-Health-Companies&v=1772630418104 "Chart of the company's future (projected) P/E Bausch Health Companies")
Future (projected) P/E of the market segment - Pharma holding
Bausch Health is a diversified pharmaceutical company that develops, manufactures, and markets a wide range of branded and generic medications, as well as medical devices. Key areas of focus include gastroenterology, dermatology, and ophthalmology. This chart reflects average expectations for the pharmaceutical industry as a whole, allowing you to assess Bausch Health's position.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-holding&v=1772630418131 "Future (projected) P/E graph of the market segment - Pharma holding")
Future (projected) P/E of the market as a whole
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in gastroenterology, ophthalmology, and dermatology. The company is undergoing a transformation and reducing its significant debt. Amidst overall market trends, BHC's key challenge is addressing its internal challenges.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772630418138 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Bausch Health Companies
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. Its revenue is generated by sales of a wide range of medications. This chart shows how the company manages its brands, copes with generic competition, and invests in new developments to sustain growth.
Profit of companies in the market segment - Pharma holding
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology (through Bausch + Lomb). This chart reflects the profitability of its pharmaceutical holdings. Its strategy includes managing established brands and developing new ones. Financial results demonstrate the company's ability to generate cash flow.
Overall market profit
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. Demand for many of its products is driven by medical needs and is relatively stable. This makes its business less sensitive to economic cycles, as can be seen in this chart.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Bausch Health Companies
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in gastroenterology, ophthalmology, and dermatology. The future profit projections shown in this chart depend on sales of key brands and successful debt management. It reflects analysts' assessment of the company's ability to stabilize its business and generate cash flow.
%20profit%20of%20the%20company%20Bausch%20Health%20Companies&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Bausch-Health-Companies&v=1772630418325 "Graph of future (projected) profit of the company Bausch Health Companies")
Future (predicted) profit of companies in the market segment - Pharma holding
Bausch Health Companies is a diversified pharmaceutical company developing and marketing a wide range of products, primarily in the fields of gastroenterology, dermatology, and ophthalmology. This chart shows profitability forecasts for the pharmaceutical holding company. It reflects overall expectations for the sector, taking into account patent cycles and competition.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-holding&v=1772630418341 "Graph of future (predicted) profits of companies in a market segment - Pharma holding")
Future (predicted) profit of the market as a whole
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology. Demand for many of its products is stable. However, the overall profit outlook reflected here impacts the company's ability to invest in R&D and marketing. A positive economic environment improves access to capital and supports growth.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772630418364 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Bausch Health Companies
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of ophthalmology, gastroenterology, and dermatology products. The P/S ratio helps evaluate the combined revenue of its various businesses as the company undergoes restructuring and debt repayment.
P/S market segment - Pharma holding
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. The company has undergone a complex restructuring. The chart shows how the market views their current portfolio and revenue generation capacity after years of transformation and divestitures.
P/S of the market as a whole
Bausch Health is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. Revenue is generated by numerous brands, but the company has a significant debt load. This chart helps understand how the market values the company's revenue, given its complex structure and financial risks.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Bausch Health Companies
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. The company is working to reduce its debt burden. This chart shows how the market views future revenue from its key brands, given its restructuring efforts and the spinoff of the Bausch + Lomb business.
%20P%2FS%20Bausch%20Health%20Companies&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Bausch-Health-Companies&v=1772630418476 "The graph of the company's future (projected) P/S Bausch Health Companies")
Future (projected) P/S of the market segment - Pharma holding
Bausch Health Companies Inc. is a diversified pharmaceutical company developing and marketing a broad range of products in gastrointestinal, dermatological, and ophthalmological fields. This chart shows how the market values the future sales of its diverse portfolio compared to other pharmaceutical holdings, reflecting its brand and debt management strategy.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20holding&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-holding&v=1772630418528 "Future (projected) P/S market segment graph - Pharma holding")
Future (projected) P/S of the market as a whole
Bausch Health is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. The company has undergone a complex restructuring. This chart shows revenue expectations for the entire market, and Bausch Health's story demonstrates how companies can adapt and find new avenues for growth after challenging times.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772630418565 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Bausch Health Companies
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology (through Bausch + Lomb). This chart shows total revenue from sales of a wide range of drugs and medical devices. The dynamics depend on the patent cycle of its key drugs and the launch of new products.
Sales of companies in the market segment - Pharma holding
Bausch Health is a diversified pharmaceutical company. This chart segments its vast business, highlighting the contribution of areas such as ophthalmology (Bausch + Lomb), gastroenterology (Salix), and dermatology. This allows investors to assess which therapeutic areas are key for the company.
Overall market sales
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. Demand for many of its products is non-cyclical, as they address pressing medical needs. This trend, coupled with the general economic situation, impacts it less than companies in the consumer sector.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Bausch Health Companies
Bausch Health is a diversified pharmaceutical company with a portfolio of products in gastroenterology, ophthalmology, and dermatology. Its revenue forecast depends on sales of key brands and generic competition. This chart shows analyst expectations for revenue stability and growth across its various business segments.
%20sales%20of%20the%20company%20Bausch%20Health%20Companies&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Bausch-Health-Companies&v=1772630418765 "Schedule of future (projected) sales of the company Bausch Health Companies")
Future (projected) sales of companies in the market segment - Pharma holding
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. This chart shows projected revenues for the entire pharmaceutical holding company. It helps assess overall market trends that impact all Bausch Health business segments.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-holding&v=1772630418788 "Schedule of future (projected) sales of companies in the market segment - Pharma holding")
Future (projected) sales of the market as a whole
Bausch Health is a diversified pharmaceutical company with products in ophthalmology, gastroenterology, and dermatology. Demand for its products is driven by demographic trends and healthcare spending. This dynamic of overall economic expectations impacts healthcare system budgets and patient solvency, which can influence sales volumes and pricing.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772630418812 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Bausch Health Companies
Bausch Health is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. This chart shows how the company manages its numerous brands. Its profitability depends on sales of key products and the ability to optimize operating expenses after a period of restructuring.
Market segment marginality - Pharma holding
Bausch Health is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. This metric reflects the combined profitability of its various business segments. Stable profitability reflects the strength of its core brands and successful management of its mature portfolio.
Market marginality as a whole
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in eye care, gastroenterology, and dermatology. The company has undergone a challenging period of restructuring. This overall profitability chart illustrates the market backdrop against which Bausch is attempting to restore investor confidence and stabilize its business.
Employees in the company, segment and market as a whole
Number of employees in the company Bausch Health Companies
Bausch Health is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology. The size of its global team, particularly in sales and marketing, reflects its efforts to promote key brands. This chart shows the combined scale of its commercial operations across various markets.
Share of the company's employees Bausch Health Companies within the market segment - Pharma holding
Bausch Health Companies is a diversified pharmaceutical company that develops and markets a wide range of products, including in ophthalmology and gastroenterology. This chart illustrates its global scale. It reflects the significant proportion of researchers, sales professionals, and manufacturing personnel across various pharmaceutical segments that Bausch employs.
Number of employees in the market segment - Pharma holding
Bausch Health Companies is a diversified pharmaceutical company with a portfolio of products in eye care, gastroenterology, and dermatology. This chart shows the overall employment within the company's pharmaceutical holdings. The dynamics of this indicator reflect the overall state of the industry, including mergers, acquisitions, and restructuring.
Number of employees in the market as a whole
Bausch Health is a diversified pharmaceutical company with a portfolio of products in ophthalmology, gastroenterology, and dermatology. Its stable employment reflects the continued demand for its medications. The company is an example of a large employer in the healthcare sector that is less susceptible to economic downturns.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Bausch Health Companies (BHC)
Bausch Health is a diversified pharmaceutical company with a portfolio of products in gastroenterology, dermatology, and ophthalmology. Their value is a combination of brands, patents, and manufacturing capacity. This chart shows that even a large pharmaceutical company with a large workforce maintains a high cost per employee due to the value of its intellectual property.
%20of%20the%20company%20Bausch%20Health%20Companies%20(BHC)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Bausch-Health-Companies-BHC&v=1772630419192 "Chart of market capitalization per employee (in thousands of dollars) of the company Bausch Health Companies (BHC)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma holding
Bausch Health is a diversified pharmaceutical company that recently spun off its successful eye care business (Bausch + Lomb). The remaining business is focused on gastroenterology and dermatology. This chart shows the industry average. It helps assess how the market values its remaining portfolio (and significant debt) per employee.
%20by%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-holding&v=1772630419210 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma holding")
Market capitalization per employee (in thousands of dollars) for the overall market
Bausch Health is a diversified pharmaceutical company with a portfolio of products in eye care, gastroenterology, and dermatology. Managing such a broad portfolio requires significant marketing and sales efforts. This chart shows how the market perceives the company's sales team's effectiveness in promoting its brands.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772630419225 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Bausch Health Companies (BHC)
Bausch Health Companies is a diversified pharmaceutical company with a troubled past (Valeant). It owns a portfolio of drugs in gastroenterology, dermatology, and ophthalmology (Bausch + Lomb). This chart shows how effectively management squeezes profits out of existing brands to cover massive debt and personnel costs.
%20Chart%20Bausch%20Health%20Companies%20(BHC)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Bausch-Health-Companies-BHC&v=1772630419254 "Company Profit Per Employee (in thousands of dollars) Chart Bausch Health Companies (BHC)")
Profit per employee (in thousands of dollars) in the market segment - Pharma holding
Bausch Health is a diversified pharmaceutical holding company (highlighted by Bausch + Lomb). It focuses on legacy drugs. This chart shows the benchmark for the Pharmaceutical Sector. In this legacy sector, the benchmark is moderate. Profit per employee is generated not by R&D, but by the efficiency of the plants producing legacy but stable drugs.
%20in%20the%20market%20segment%20-%20Pharma%20holding&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-holding&v=1772630419269 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma holding")
Profit per employee (in thousands of dollars) for the market as a whole
Bausch Health is a diversified pharmaceutical company. After spinning off Bausch + Lomb (eyes), they focused on gastrointestinal (GI) and dermatology. This chart, showing the average market profitability per employee, helps understand the effectiveness of the pharmaceutical sector represented by BHC.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772630419355 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Bausch Health Companies (BHC)
Bausch Health Companies, a diversified pharmaceutical company, uses this chart to show the combined performance of its divisions, from ophthalmology to gastroenterology. Revenue per employee reflects the commercial success of its brand portfolio. This indicator's dynamics depend on the life cycle of key drugs and the launch of new products.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Bausch-Health-Companies-BHC&v=1772630419378 "Sales chart per company employee Bausch Health Companies (BHC)")
Sales per employee in the market segment - Pharma holding
Bausch Health is a diversified pharmaceutical company focused on gastroenterology and dermatology (following the spinoff of Bausch + Lomb). This chart shows the average revenue per employee in this segment. It helps assess how effectively BHC's commercial and R&D teams manage their drug portfolio compared to competitors.
Sales per employee for the market as a whole
Bausch Health (BHC) is a diversified pharmaceutical company with a portfolio of gastrointestinal and ophthalmology products. This metric reflects how effectively the company manages its portfolio, which includes many mature drugs. It needs to maximize revenue from these products to pay off debt and invest in new developments.
Short shares by company, segment and market as a whole
Shares shorted by company Bausch Health Companies (BHC)
Bausch Health is a pharmaceutical holding company burdened with massive debt following an aggressive M&A strategy (formerly Valeant). The company owns Bausch + Lomb (eyes) and Salix (gastrointestinal tract). This chart demonstrates a lack of confidence in its survival. Bears are betting that the company will be unable to service its debt and will be forced to sell off assets or restructure.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Bausch-Health-Companies-BHC&v=1772630419539 "Short Shares Chart for the Company Bausch Health Companies (BHC)")
Shares shorted by market segment - Pharma holding
Bausch Health is a diversified pharmaceutical company with a large portfolio of drugs (gastroenterology, ophthalmology) and a huge debt load. This chart shows the pessimism in the pharmaceutical sector. The increase in short positions in the industry may be related to concerns about patent cliffs on key drugs, which is especially dangerous for a company with high debt like BHC.
Shares shorted by the overall market
Bausch Health Companies (BHC) is a diversified pharmaceutical company with a portfolio of products in eye care (Bausch + Lomb), gastroenterology, and dermatology. This chart shows the overall level of fear in the market. For a company with a highly leveraged position like BHC, rising market pessimism is a serious threat. It complicates debt refinancing and makes investors nervous about its financial stability.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Bausch Health Companies (BHC)
Bausch Health is a diversified pharmaceutical company with a high debt load. The stock is volatile. A chart reading above 70 may reflect progress in debt restructuring or asset sales. A reading below 30 often indicates concerns about debt, lawsuits, or weak sales.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Bausch-Health-Companies-BHC&v=1772630419582 "RSI 14 indicator chart for the company's stock Bausch Health Companies (BHC)")
RSI 14 Market Segment - Pharma holding
Bausch Health Companies is a diversified pharmaceutical company. Following the spinoff of Bausch + Lomb, it is now focused on gastrointestinal (Xifaxan) and dermatology products. This chart measures the overall momentum in the specialty pharmaceuticals sector. It helps understand how investors view BHC's portfolio relative to the overall health of the pharmaceutical industry.
RSI 14 for the overall market
Bausch Health (BHC) is a diversified pharmaceutical holding. This chart is important to them as an indicator of risk appetite for companies with high debt loads. During periods of euphoria, investors ignore debt. In times of panic, the focus shifts to the balance sheet, and indebted companies like BHC come under severe pressure.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast BHC (Bausch Health Companies)
Bausch Health (BHC) is a diversified pharmaceutical company with interests in gastroenterology (Xifaxan) and ophthalmology (Bausch + Lomb, which was partially spun off). The chart shows the average analyst forecast, reflecting their complex assessment of the company's massive debt and the cash flow-generating capacity of its remaining brands.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-BHC-Bausch-Health-Companies&v=1772630419669 "A chart showing analyst consensus forecasts for the expected stock price. BHC (Bausch Health Companies)")
The difference between the consensus estimate and the actual stock price BHC (Bausch Health Companies)
Bausch Health is a diversified pharmaceutical company that, after spinning off its lens business (Bausch + Lomb), focused on gastroenterology and other niches. This chart shows the gap between the current market valuation and analyst target price. It indicates whether experts believe in the company's ability to manage debt and grow.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-BHC-Bausch-Health-Companies&v=1772630419683 "A chart showing the difference between the consensus forecast and the actual stock price. BHC (Bausch Health Companies)")
Analyst consensus forecast for stock prices by market segment - Pharma holding
Bausch Health (BHC) is what remains of the controversial Valeant. It is now a diversified holding company focused on eye health (Bausch + Lomb) and gastroenterology. This chart shows analysts' overall expectations for all of Big Pharma. It reflects whether experts believe the company can service its debt.
Analysts' consensus forecast for the overall market share price
Bausch Health (BHC) is the remnant of the Valeant empire. It's a diversified pharmaceutical holding (gastroenterology, dermatology) with a huge debt load. (Note: Bausch + Lomb (BLCO) has been highlighted.) This chart, reflecting expert expectations, influences them. In a downturn (pessimism), their protective products are stable, but investors are concerned about their debt in a rising interest rate environment.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Bausch Health Companies
Bausch Health is a Canadian pharmaceutical company with a diversified portfolio (eye care, gastroenterology). The company underwent a difficult restructuring following scandals. This chart is a reversal indicator. It likely reflects their ability to manage massive debt, stabilize earnings, and successfully spin off assets (like Bausch + Lomb).
AKIMA Market Segment Index - Pharma holding
Bausch Health (BHC) is a pharmaceutical holding company (formerly Valeant), which (after debt restructuring) owns a diversified portfolio of brands in gastroenterology (Salix) and aesthetics. This consolidated metric evaluates companies. The graph shows the average value for the segment. This is a benchmark: how does BHC's post-crisis model (and its enormous debt) differentiate it from the average pharmaceutical company?
The AKIM Index for the overall market
Bausch Health (BHC) is a holding company that (following the B+L spinoff) owns a pharmaceutical business focused on gastroenterology (stomach) and dermatology. It's a defensive (healthcare) but mature business. This chart, which reflects the market average, provides a macro backdrop. It helps assess how BHC compares to the overall macroeconomic picture affecting the sector.
